Developmental basis of SHH medulloblastoma heterogeneity.
Saved in:
| Title: | Developmental basis of SHH medulloblastoma heterogeneity. |
|---|---|
| Authors: | Gold MP; Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA., Ong W; Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada., Masteller AM; Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA., Ghasemi DR; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro-oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Heidelberg, Germany., Galindo JA; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles (CHLA), Los Angeles, CA, USA., Park NR; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.; Department of Molecular Biology, Princeton University, Princeton, NJ, USA.; Ludwig Institute for Cancer Research, Princeton University, Princeton, NJ, USA., Huynh NC; Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA., Donde A; Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA., Pister V; Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA., Saurez RA; Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada., Vladoiu MC; Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada., Hwang GH; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurobiology, Harvard Medical School, Boston, MA, USA., Eisemann T; Cancer Genome and Epigenetics Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA., Donovan LK; Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada., Walker AD; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles (CHLA), Los Angeles, CA, USA., Benetatos J; Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA., Dufour C; Department of Child and Adolescent Oncology, Gustave Roussy, Villejuif, France.; INSERM U981, Molecular Predictors and New Targets in Oncology, University Paris-Saclay, Villejuif, France., Garzia L; Cancer Research Program, McGill University, Montreal, QC, Canada.; MUHC Research Institute, McGill University, Montreal, QC, Canada., Segal RA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurobiology, Harvard Medical School, Boston, MA, USA., Wechsler-Reya RJ; Cancer Genome and Epigenetics Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.; Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, NY, USA.; Department of Neurology, Columbia University Medical Center, New York, NY, USA., Mesirov JP; Department of Medicine, Moores Cancer Center, UC San Diego, La Jolla, CA, USA., Korshunov A; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology (B300), German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany., Pajtler KW; Hopp-Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neuro-oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, and Immunology, Heidelberg University Hospital, Heidelberg, Germany., Pomeroy SL; Department of Neurology, Boston Children's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ayrault O; Institut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France.; Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay, France., Davidson SM; Lewis-Sigler Institute for Integrative Genomics, Princeton University, Princeton, NJ, USA.; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.; Division of Pulmonary and Critical Care Medicine, Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA., Cotter JA; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles (CHLA), Los Angeles, CA, USA.; Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Taylor MD; Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada.; Division of Neurosurgery, The Hospital for Sick Children, Toronto, ON, Canada.; Department of Surgery, University of Toronto, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Texas Children's Cancer Center, Hematology-Oncology Section, Houston, TX, USA.; Department of Pediatrics - Hematology/Oncology and Neurosurgery, Baylor College of Medicine, Houston, TX, USA., Fraenkel E; Department of Biological Engineering, Massachusetts Institute of Technology (MIT), Cambridge, MA, USA. fraenkel-admin@mit.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. fraenkel-admin@mit.edu. |
| Source: | Nature communications [Nat Commun] 2024 Jan 08; Vol. 15 (1), pp. 270. Date of Electronic Publication: 2024 Jan 08. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-023-44300-0 |
